Clinical trial
Evaluating the Safety and Efficacy of Atrial Shunt Implantation Systems for the Treatment of Patients With Chronic Left Heart Failure Prospective, Multicenter, Single-group Target Value Clinical Trials
NCT05486000 is registered in ClinicalTrials.gov with Morningside (Nantong) Medical Co.,Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Safety and Efficacy of Atrial Shunt Implantation Systems for the Treatment of Patients With Chronic Left Heart Failure Prospective, Multicenter, Single-group Target Value Clinical Trials
- Lead sponsor
- Morningside (Nantong) Medical Co.,Ltd
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 31, 2022
- Completion date
- October 31, 2026
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
left heart failure